MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'fanapt'. Sat, 03 Sep 2011 03:34:41 +0100 http://www.medworm.com/index.php?rid=4507576&cid=t_306258_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fhf6Mo6pHvdw%2F The FDA issued a safety alert today about the risks of exposure of nearly two dozen antipsychotics to newborns when the drugs are taken by women during pregnancy. Specifically, the pregnancy section of drug labeling for the entire class was updated to include info about the potential risk for abnormal muscle movements (extrapyramidal signs or EPS) and withdrawal symptoms in newborns. In searching its adverse events database, the agency has, so far, identified 69 cases of neonatal EPS or withdrawal through October 29, 2008, involving all antipsychotics. The symptoms of EPS and withdrawal in newborns may include agitation, abnormally increased or decreased muscle tone, tremor, sleepiness, severe difficulty breathing, and difficulty in feeding. And symptoms varied in severity: in some newborn... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4507576 Tue, 22 Feb 2011 23:28:04 +0100 4507576 http://www.medworm.com/index.php?rid=3581840&cid=t_306258_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FsDS6HDFg2Xo%2F And so another day begins. Our immediate challenge is hustling the short people off to their respective schoolhouses. This calls for a cup or three of stimulation. Meanwhile, the usual meetings and deadlines loom, although we look forward to a gathering this evening of industry types. As we all prepare for what lies ahead, here are a few items to help you along. Have a good one… German Court Rules Glaxo’s Advair Patent Isn’t Valid (Reuters) Piramal Downplays Takeover Rumors (PharmaTimes) Vanda Schizophrenia Drugs Gets Bad Review (TheStreet) PhRMA Spent $7M Lobbying DC In 1st Quarter (Associated Press) Roche Diagnostics Insists It’s Growing (Indianapolis Star) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3581840 Thu, 20 May 2010 11:47:18 +0100 3581840 http://www.medworm.com/index.php?rid=2996015&cid=t_306258_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F11%2Ftitan-pharmaceuticals-inc-new-fanapt.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2996015 Mon, 16 Nov 2009 02:54:00 +0100 2996015 http://www.medworm.com/index.php?rid=2993925&cid=t_306258_140_f&fid=35439&url=http%3A%2F%2Fbipolarsoupkitchen-stephany.blogspot.com%2F2009%2F11%2Fvanda-fanapt-another-marketing-target.html (Source: soulful sepulcher) soulful sepulcher blogs http://www.medworm.com/rss/comments.php?id=2993925 Sun, 15 Nov 2009 02:52:00 +0100 2993925 http://www.medworm.com/index.php?rid=2398856&cid=t_306258_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FvKNFgNsDr2I%2F The United States FDA has granted marketing approval to a new drug to help treat schizophrenia. Called Fanapt (iloperidone), the medication is intended to treat adults with schizophrenia while in the acute phases. It isn’t yet known how long they should be kept on the medication once the acute phases is over, but researchers agree that if the patient is responding, continuing with the treatment is encouraged. According to a company press release , “The approval was supported by two placebo-controlled Phase III clinical studies comparing Fanapt(TM) to placebo and active control in patients with schizophrenia, as well as safety data from more than 3,000 patients.” Schizophrenia is a fairly common mental illness, estimated to strike one out of every 100 people in North Amer... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2398856 Sat, 09 May 2009 15:02:46 +0100 2398856